The influence of base sequence on the immunostimulatory properties of DNA

Immunologic Research

Volumn 19, Issue 1, 1999, Pages 35-46

  Pisetsky, David S ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Antisense; Cytokines; DNA; Host defense; Immunostimulation; Phosphorothioates

Indexed keywords

BACTERIAL DNA; CYTOSINE; DEOXYGUANOSINE; DINUCLEOTIDE; DNA; DNA BASE; GUANINE; OLIGONUCLEOTIDE;

B LYMPHOCYTE ACTIVATION; CELL STIMULATION; COMPARATIVE STUDY; CYTOKINE PRODUCTION; DNA SEQUENCE; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; IMMUNOSTIMULATION; MACROPHAGE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

EID: 0033065988     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02786475     Document Type: Review

References (60)

1. Tokunaga T, Yano O, Kuramoto E, Kimura Y, Yamamoto T, Kataoka T, et al.: Synthetic oligonucleotides with particular base sequences from the cDNA encoding proteins of Mycobacterium bovis BCG induce interferons and activate natural killer cells. Microbiol Immunol 1992;36:55-66.
2. Krieg AM, Yyi A-K, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R, et al.: CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 1995; 374:546-549.
3. Pisetsky DS: Immunostimulatory DNA: A clear and present danger? Nature Med 1997;3:829-831.
4. Pisetsky DS: Immune activation by bacterial DNA: A new genetic code. Immunity 1996;5:303-310.
5. Pisetsky DS: The immunologic properties of DNA. J Immunol 1996;156:421-423.
6. Tokunaga T, Yamamoto II, Shimada S, Abe H, Fukuda T, Fujisawa Y, et al.: Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity. J Natl Can Inst 1984;72: 955-962.
7. Shimada S, Yano O, lnoue H, Kuramoto E, Fukuda T, Yamamote H, et al.: Antitumor activity of the DNA fraction from Mycobacterium bovis BCG. II. Effects on various syngeneic mouse tumors. J Natl Can Inst 1985;74:681-688.
8. Braun W, Nakano M: Influence of oligodeoxyribonucleotides on early events in antibody formation. Proc SocExpBiol Med 1965; 119:701-707.
9. Vogt W, Ruhl H, Wagner B, Diamantstein T: Stimulation of DNA synthesis in mouse lymphoid cells by polyanions in vitro. II. Relationship between adjuvant activity and stimulation of DNA synthesis by polyanions. Eur J Immunol 1973;3:493-496.
10. Yamamoto S, Yamamoto T, Kataoka T, Kuramoto E, Yano O, Tokunaga T: Unique palindromic sequences in synthetic oligonucleotides are required to induce INF and augment INF-mediated natural killer activity. J Immunol 1992; 148:4072-4076.
11. Yamamoto T, Yamamoto S, Kataoka T, Komuro K, Kohase M, Tokunaga T: Synthetic oligonucleotides with certain palindromes stimulate inteferon production of human peripheral blood lymphocytes in vitro. Jpn J Cancer Res 1994;85:775-779.
12. Yamamoto S, Yamamoto T, Shimada S, Kuramoto E, Yano O. Kataoka T, et al.: DNA from bacteria, but not from vertebrates, induces interferons, activates natural killer cells and inhibits tumor growth. Microbiol Immunol 1992;36:983-997.
13. Messina JP, Gilkeson GS, Pisetsky DS: Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA. J Immunol 1991;147:1759-1764.
14. Halpern MD, Kurlander RJ, Pisetsky DS: Bacterial DNA induces murine interferon-γ production by stimulation of interleukin-12 and tumor necrosis factor-α. Cell Immunol 1996;167:72-78.
15. Klinman DM, Yi A-K, Beaucage SL, Conover J, Krieg AM: CpG motifs presents in bacterial DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon γ. Proc Natl Acad Sci USA 1996;93:2879-2883.
16. Cowdery JS, Chace JH, Yi A-K, Krieg AM: Bacterial DNA induces NK cells to produce IFN-γ in vivo and increases the toxicity of lipopolysaccharides. J Immunol 1996; 156:4570-4575.
17. Yi A-K, Chace JH, Cowdery JS, Krieg AM: IFN-γ promotes IL-6 and IgM secretion in response to CpG motifs in bacterial DNA and oligodeoxynucleotides. J Immunol 1996;156:558-564.
18. Liang H, Nishioka Y, Reich CF, Pisetsky DS, Lipsky PE: Activation of human B cells by phosphorothioate oligodeoxynucleotides. J Clin Invest 1996:98: 1119-1129.
19. Bird AP: CpG islands as gene markers in the vertebrate nucleus. Trends Genet 1987;3:342-346.
20. Hergersberg M: Biological aspects of cytosine methylation in eukaryotic cells. Experientia 1991;47: 1171-1185.
21. Burge C, Campbell AM, Karlin S: Over- and under-representation of short oligonucleotidcs in DNA sequences. Proc Natl Acad Sci USA 1992;89:1358-1362.
22. Bird AP: Functions for DNA methylation in vertebrates. Cold Harbor Symp Quant Biol 1993; 58:281-285.
23. Doerfler W: Patterns of DNA methylation - Evolutionary vestiges of foreign DNA inactivation as a host defense mechanism. A proposal. Biol Chem Hoppe-Seyler 1991;372:557-564.
24. Sun S, Beard C, Jaenisch R, Jones P, Sprent J: Mitogenicity of DNA from different organisms for murine B cells. J Immunol 1997;159:3119-3125.
25. Pisetsky DS, Reich C: Stimulation of in vitro proliferation of murine lymphocytes by synthetic oligodeoxynucleotides. Mol Biol Rep 1993;18:217-221.
26. Messina JP. Gilkeson GS, Pisetsky DS: The influence of DNA structure on the in vitro stimulation of murine lymphocytes by natural and synthetic polynucleotide antigens. Cell Immunol 1993;147:148-157.
27. Kimura Y, Sonehara K, Kuramoto E, Makino T, Yamamoto S, Yamamoto T, et al.: Binding of oligoguanylate to scavenger receptors is required for oligonucleotides to augment NK cell activity and induce IFN. J Biochem 1994;116:991-994.
28. Williamson JR: G-quartet structures in telomeric DNA. Annu Rev Biophys Biomol Struct 1994;23:703-730.
29. Zakian VA: Telomeres: Beginning to understand the end. Science 1995;270:1601-1607.
30. Kodama T, Freeman M, Rohrer L, Zabrecky J, Matsudaira P, Krieger M: Type I macrophage scavenger receptor contains α-helical and collagen-like coiled coils. Nature 1990;343:531-535.
31. Krieger M, Herz J: Structures and functions of multiligand lipoprotein receptors: Macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu Rev Biochem 1994;63:601-637.
32. Pearson AM, Rich A, Krieger M: Polynucleotide binding to macrophage scavenger receptors depends on the formation of base-quarter-stabilized four-stranded helices. J Biol Chem 1993;268:3546-3554.
33. Haworth R, Platt N, Keshav S, Hughes D, Darley E, Suzuki H, et al.: The macrophage scavenger receptor type A is expressed by activated macrophages and protects the host against lethal endotoxic shock. J Exp Med 1997;186:1431-1439.
34. Haberland ME, Rasmussen RR, Fogelman AM: Receptor recognition of malcyl-albumin induces chemotaxis in human monocytes. J Clin Invest 1986;78:827-831.
35. Frostegard J, Nilsson J, Haegerstrand A, Hamsten A, Wigzell H, Gidlund M: Oxidized low density lipoprotein induces differentiation and adhesion of human monocytes and the monocytic cell line U937. Proc Natl Acad Sci 1990;87:904-908.
36. Pisetsky DS, Reich CF: The influence of base sequence on the immunological properties of defined oligonucleotides. Immunopharmacology 1998;40:199-208.
37. RC5) cells. Antisense Res Dev 1994;4:211-215.
38. Yi A-K, Tuetken R, Redford T, Waldschmidt M, Kirsch J. Krieg AM: CpG motifs in bacterial DNA activate leukocytes through the pH-dependent generation of reactive oxygen species. J Immunol 1998;160:4755-4761.
39. Vogel FR, Sarver N: Nucleic acid vaccines. Clin Microbiol Rev 1995;8:406-410.
40. Pardoll DM, Beckerleg AM: Exposing the immunology of naked DNA vaccines. Immunity 1995;3:165-169.
41. Corr M, Lee DJ, Carson DA, Tighe H: Gene vaccination with naked plasmid DNA: Mechanism of CTL priming. J Exp Mud 1996;184:1555-1560.
42. Iwasaki A, Torres CAT, Ohashi PS, Robinson HL, Barber BH: The dominant role of bone marrow-derived cells in CTL induction following plasmid DNA immunization at different sites. J Immunol 1997;159:11-14.
43. Sato Y, Roman M, Tighe H, Lee D, Corr M, Nguyen M-D, et al.: Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 1996;273:352-354.
44. Klinman DM, Yamshchikov G, Ishigatsubo Y: Contribution of CpG motifs to the immunogenicity of DNA vaccines. J Immunol 1997;158:3635-3639.
45. Wloch MK, Pasquini S, Ertl HCJ, Pisetsky DS: The influence of DNA sequence on the immunostimulatory properties of plasmid DNA vectors. Hum Gent Ther 1998;9:1439-1447.
46. Kawabata K, Takakura Y, Hashida M: The fate of plasmid DNA after intravenous injection in mice: Involvement of scavenger receptors in its hepatic uptake. Pharm Res 1995;12:825-830.
47. Sawai K, Mahato RI, Oka Y, Takakura Y, Hashida M: Diposition of oligonucleotides in isolated perfused rat kidney: Involvement of scavenger receptors in their renal uptake. J Pharmacol Exp Ther 1996;279:284-290.
48. Stein CA. Cheng YC: Antisense oligonucleotides as therapeutic agents - Is the bullet really magical? Science 1993;261:1004-1012.
49. Frey PA, Sammons RD: Bond order and charge localization in nucleoside phosphorothioates. Science 1985;228:541-545.
50. Stein CA, Subasinghe C, Shinozuka K. Cohen JS: Physicochemical properties of phosphorothioate oligodeoxynucleotides. Nucleic Acids Res 1988;16:3209-3221.
51. Raz E, Tighe H, Sato Y, Corr M, Dudler JA, Roman M, et al.: Preferential induction of a Thl immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proc Natl Acad Sci USA 1996;93:5141-5145.
52. Lipford GB, Bauer M, Blank C, Reiter R, Wagner H, Heeg K: CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: A new class of vaccine adjuvants. Eur J Immunol 1997;27:2340-2344.
53. Sun S, Kishimoto H, Sprent J: DNA as an adjuvant: Capacity of insect DNA and synthetic oligodeoxynucleotides to augment T cell responses to specific antigen. J Exp Med 1998;187:1145-1150.
54. Zimmermann S, Egeter O, Hausmann S, Lipford GB, Rocken M, Wagner H, et al.: Cutting Edge: CpG oligodeoxynucleotides trigger protective and curative Thl responses in lethal murine Leishmaniasis. J Immunol 1998;160: 3627-3630.
55. Agrawal S, Temsamani J, Galbraith W, Tang J: Pharmacokinetics of antisense oligonucleotides. Clin Pharmacokinet 1995;28:7-16.
56. Zhao Q, Temsamani J, Iadamla PL, Jiang Z, Agrawal S: Effect of different chemically modified oligodeoxynucleotides on immune stimulation. Biochem Pharm 1996;51:173-182.
57. Monteith DK, Henry SP, Howard RB, Flournoy S, Levin AA, Bennett CF, et al.: Immune stimulation - A class effect of phosphorothioate oligodeoxynucleotides in rodents. Anticancer Drug Design 1997;12:421-432.
58. Yakubov I., Khaled Z, Zhang L-M, Truneh A, Vlassov V, Stein CA: Oligodeoxynucleotides interact with recombinant CD4 at multiple sites. J Biol Chem 1993;268:18,818-18,823.
59. Brown DA, Kang S-H, Gryaznov SM, Dedionisio L, Heidenreich O, Sullivan S, et al.: Effect of phosphorothioate modification of oligodeoxynucleotides on specific protein binding. J Biol Chem 1994;269:26,801-26,805.
60. Benimetskaya L, Loike JD, Khaled Z, Loike G, Silverstein SC, Cao L, et al.: Mac-1 (CD11b/CD18) is an oligodeoxynucleotide-binding protein. Nature Med 1997;3: 414-420.